President and CEO of Precision Biosciences Inc (NASDAQ:DTIL), Kane Matthew R., sells 9,741 shares worth $84,454
According to Precision Biosciences Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 14 04:37 PM, company President and CEO, Kane Matthew R. disclosed selling 9,741 shares at a cost of $8.67. At the time of this transaction (Apr 12), this trade was worth $84,454 in total. As of Apr 12, Kane Matthew R. now owns 1,964,796 shares in total worth about $17,113,373.16.
For the last few recent trades made by Precision Biosciences Inc (NASDAQ:DTIL) President and CEO, Kane Matthew R., we have the following information:
- SEC Form 4 filing: Apr 08: Sold 9,736 shares at the rate of $9.00 per share. Total worth of this trade was $87,624. Total number of shares owned as of Apr 08 were 1,941,246
- SEC Form 4 filing: Apr 09: Sold 9,737 shares at the rate of $8.87 per share. Total worth of this trade was $86,367. Total number of shares owned as of Apr 09 were 1,953,023
- SEC Form 4 filing: Mar 12: Sold 9,712 shares at the rate of $11.36 per share. Total worth of this trade was $110,328. Total number of shares owned as of Mar 12 were 1,929,468
Posted by
George Daniels
on Wednesday April 14 2021, 7:17 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
